Search Results 2591-2600 of 16617 for Epilepsy (Partial Onset)

  1. Publications

    Early Onset Preeclampsia Is Associated With Glycocalyx Degradation and Reduced Microvascular Perfusion. J Am Heart Assoc. 2019 Feb 19; 8 (4):e010647. View ...

  2. Acute Myelogenous Leukemia Clinical Trials

    The duration of the study is expected to be approximately 30 months. Study to Evaluate the Safety and Efficacy of Magrolimab in Combination With Azacitidine ...

  3. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

    * Onset of autoimmune encephalitis (AIE) symptoms \<=9 months before randomization * Meet the definition of "New Onset" or "Incomplete Responder" AIE * For ...

  4. A Drug-drug Interaction Study of Avapritinib and Midazolam to Treat Unresectable or Metastatic Gastrointestinal Stromal Tumors and Other Advanced Solid Tumors - Mayo Clinic

    Have history of a seizure disorder (eg, epilepsy) or requirement for anticonvulsant medications. Have history of a cerebrovascular accident or transient ...

  5. Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD - Mayo Clinic

    This study is to assess the safety, tolerability, preliminary efficacy, and pharmacokinetics of APL-2 in subjects with warm Autoimmune Hemolytic Anemia (wAIHA) ...

  6. Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis - Mayo Clinic

    Disease duration of ≤ 18 months (defined as time from the first non−Raynaud's phenomenon manifestation); ≥ 10 and ≤ 22 mRSS (modified Rodnan skin score) ...

  7. A Study to Evaluate The Effectiveness and Safety of Abrocitinib, with or without Topical Medications, in Subjects Aged 12 Years and Older with Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

    Female subjects of childbearing potential must agree to use a highly effective method of contraception for the duration of the active treatment period and ...

  8. Neurology - Clinical trials - Mayo Clinic

    ... epileptic focus requiring temporal lobectomy or a glioma. Devices used for microperfusion are Joanneum Research's cerebral open flow microperfusion (OFM) ...

  9. Medical Research & Education - Mayo Clinic News Network

    ... epilepsy. ROCHESTER, Minn. — A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo ...

  10. Medical Research & Education - Mayo Clinic News Network

    (VIDEO) When seizures don't stop: The battle against drug-resistant epilepsy. For Anthony Maita, 'Buddy' is not just any other dog.